Cargando…

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions

Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors—distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogumil, Henri, Sill, Martin, Schrimpf, Daniel, Ismer, Britta, Blume, Christina, Rahmanzade, Ramin, Hinz, Felix, Cherkezov, Asan, Banan, Rouzbeh, Friedel, Dennis, Reuss, David E., Selt, Florian, Ecker, Jonas, Milde, Till, Pajtler, Kristian W., Schittenhelm, Jens, Hench, Jürgen, Frank, Stephan, Boldt, Henning B., Kristensen, Bjarne Winther, Scheie, David, Melchior, Linea C., Olesen, Viola, Sehested, Astrid, Boué, Daniel R., Abdullaev, Zied, Satgunaseelan, Laveniya, Kurth, Ina, Seidlitz, Annekatrin, White, Christine L., Ng, Ho-Keung, Shi, Zhi-Feng, Haberler, Christine, Deckert, Martina, Timmer, Marco, Goldbrunner, Roland, Tauziède-Espariat, Arnault, Varlet, Pascale, Brandner, Sebastian, Alexandrescu, Sanda, Snuderl, Matija, Aldape, Kenneth, Korshunov, Andrey, Witt, Olaf, Herold-Mende, Christel, Unterberg, Andreas, Wick, Wolfgang, Pfister, Stefan M., von Deimling, Andreas, Jones, David T. W., Sahm, Felix, Sievers, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119244/
https://www.ncbi.nlm.nih.gov/pubmed/36933012
http://dx.doi.org/10.1007/s00401-023-02558-0
_version_ 1785028983793909760
author Bogumil, Henri
Sill, Martin
Schrimpf, Daniel
Ismer, Britta
Blume, Christina
Rahmanzade, Ramin
Hinz, Felix
Cherkezov, Asan
Banan, Rouzbeh
Friedel, Dennis
Reuss, David E.
Selt, Florian
Ecker, Jonas
Milde, Till
Pajtler, Kristian W.
Schittenhelm, Jens
Hench, Jürgen
Frank, Stephan
Boldt, Henning B.
Kristensen, Bjarne Winther
Scheie, David
Melchior, Linea C.
Olesen, Viola
Sehested, Astrid
Boué, Daniel R.
Abdullaev, Zied
Satgunaseelan, Laveniya
Kurth, Ina
Seidlitz, Annekatrin
White, Christine L.
Ng, Ho-Keung
Shi, Zhi-Feng
Haberler, Christine
Deckert, Martina
Timmer, Marco
Goldbrunner, Roland
Tauziède-Espariat, Arnault
Varlet, Pascale
Brandner, Sebastian
Alexandrescu, Sanda
Snuderl, Matija
Aldape, Kenneth
Korshunov, Andrey
Witt, Olaf
Herold-Mende, Christel
Unterberg, Andreas
Wick, Wolfgang
Pfister, Stefan M.
von Deimling, Andreas
Jones, David T. W.
Sahm, Felix
Sievers, Philipp
author_facet Bogumil, Henri
Sill, Martin
Schrimpf, Daniel
Ismer, Britta
Blume, Christina
Rahmanzade, Ramin
Hinz, Felix
Cherkezov, Asan
Banan, Rouzbeh
Friedel, Dennis
Reuss, David E.
Selt, Florian
Ecker, Jonas
Milde, Till
Pajtler, Kristian W.
Schittenhelm, Jens
Hench, Jürgen
Frank, Stephan
Boldt, Henning B.
Kristensen, Bjarne Winther
Scheie, David
Melchior, Linea C.
Olesen, Viola
Sehested, Astrid
Boué, Daniel R.
Abdullaev, Zied
Satgunaseelan, Laveniya
Kurth, Ina
Seidlitz, Annekatrin
White, Christine L.
Ng, Ho-Keung
Shi, Zhi-Feng
Haberler, Christine
Deckert, Martina
Timmer, Marco
Goldbrunner, Roland
Tauziède-Espariat, Arnault
Varlet, Pascale
Brandner, Sebastian
Alexandrescu, Sanda
Snuderl, Matija
Aldape, Kenneth
Korshunov, Andrey
Witt, Olaf
Herold-Mende, Christel
Unterberg, Andreas
Wick, Wolfgang
Pfister, Stefan M.
von Deimling, Andreas
Jones, David T. W.
Sahm, Felix
Sievers, Philipp
author_sort Bogumil, Henri
collection PubMed
description Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors—distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using an unsupervised visualization approach of DNA methylation data, we identified a novel group of tumors (n = 20) that formed a cluster separate from all established CNS tumor types. Molecular analyses revealed ATRX alterations (in 16/16 cases by DNA sequencing and/or immunohistochemistry) as well as potentially targetable gene fusions involving receptor tyrosine-kinases (RTK; mostly NTRK1-3) in all of these tumors (16/16; 100%). In addition, copy number profiling showed homozygous deletions of CDKN2A/B in 55% of cases. Histological and immunohistochemical investigations revealed glioneuronal tumors with isomorphic, round and often condensed nuclei, perinuclear clearing, high mitotic activity and microvascular proliferation. Tumors were mainly located supratentorially (84%) and occurred in patients with a median age of 19 years. Survival data were limited (n = 18) but point towards a more aggressive biology as compared to other glioneuronal tumors (median progression-free survival 12.5 months). Given their molecular characteristics in addition to anaplastic features, we suggest the term glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA) to describe these tumors. In summary, our findings highlight a novel type of glioneuronal tumor driven by different RTK fusions accompanied by recurrent alterations in ATRX and homozygous deletions of CDKN2A/B. Targeted approaches such as NTRK inhibition might represent a therapeutic option for patients suffering from these tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02558-0.
format Online
Article
Text
id pubmed-10119244
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-101192442023-04-22 Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions Bogumil, Henri Sill, Martin Schrimpf, Daniel Ismer, Britta Blume, Christina Rahmanzade, Ramin Hinz, Felix Cherkezov, Asan Banan, Rouzbeh Friedel, Dennis Reuss, David E. Selt, Florian Ecker, Jonas Milde, Till Pajtler, Kristian W. Schittenhelm, Jens Hench, Jürgen Frank, Stephan Boldt, Henning B. Kristensen, Bjarne Winther Scheie, David Melchior, Linea C. Olesen, Viola Sehested, Astrid Boué, Daniel R. Abdullaev, Zied Satgunaseelan, Laveniya Kurth, Ina Seidlitz, Annekatrin White, Christine L. Ng, Ho-Keung Shi, Zhi-Feng Haberler, Christine Deckert, Martina Timmer, Marco Goldbrunner, Roland Tauziède-Espariat, Arnault Varlet, Pascale Brandner, Sebastian Alexandrescu, Sanda Snuderl, Matija Aldape, Kenneth Korshunov, Andrey Witt, Olaf Herold-Mende, Christel Unterberg, Andreas Wick, Wolfgang Pfister, Stefan M. von Deimling, Andreas Jones, David T. W. Sahm, Felix Sievers, Philipp Acta Neuropathol Original Paper Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors—distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using an unsupervised visualization approach of DNA methylation data, we identified a novel group of tumors (n = 20) that formed a cluster separate from all established CNS tumor types. Molecular analyses revealed ATRX alterations (in 16/16 cases by DNA sequencing and/or immunohistochemistry) as well as potentially targetable gene fusions involving receptor tyrosine-kinases (RTK; mostly NTRK1-3) in all of these tumors (16/16; 100%). In addition, copy number profiling showed homozygous deletions of CDKN2A/B in 55% of cases. Histological and immunohistochemical investigations revealed glioneuronal tumors with isomorphic, round and often condensed nuclei, perinuclear clearing, high mitotic activity and microvascular proliferation. Tumors were mainly located supratentorially (84%) and occurred in patients with a median age of 19 years. Survival data were limited (n = 18) but point towards a more aggressive biology as compared to other glioneuronal tumors (median progression-free survival 12.5 months). Given their molecular characteristics in addition to anaplastic features, we suggest the term glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA) to describe these tumors. In summary, our findings highlight a novel type of glioneuronal tumor driven by different RTK fusions accompanied by recurrent alterations in ATRX and homozygous deletions of CDKN2A/B. Targeted approaches such as NTRK inhibition might represent a therapeutic option for patients suffering from these tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02558-0. Springer Berlin Heidelberg 2023-03-18 2023 /pmc/articles/PMC10119244/ /pubmed/36933012 http://dx.doi.org/10.1007/s00401-023-02558-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Bogumil, Henri
Sill, Martin
Schrimpf, Daniel
Ismer, Britta
Blume, Christina
Rahmanzade, Ramin
Hinz, Felix
Cherkezov, Asan
Banan, Rouzbeh
Friedel, Dennis
Reuss, David E.
Selt, Florian
Ecker, Jonas
Milde, Till
Pajtler, Kristian W.
Schittenhelm, Jens
Hench, Jürgen
Frank, Stephan
Boldt, Henning B.
Kristensen, Bjarne Winther
Scheie, David
Melchior, Linea C.
Olesen, Viola
Sehested, Astrid
Boué, Daniel R.
Abdullaev, Zied
Satgunaseelan, Laveniya
Kurth, Ina
Seidlitz, Annekatrin
White, Christine L.
Ng, Ho-Keung
Shi, Zhi-Feng
Haberler, Christine
Deckert, Martina
Timmer, Marco
Goldbrunner, Roland
Tauziède-Espariat, Arnault
Varlet, Pascale
Brandner, Sebastian
Alexandrescu, Sanda
Snuderl, Matija
Aldape, Kenneth
Korshunov, Andrey
Witt, Olaf
Herold-Mende, Christel
Unterberg, Andreas
Wick, Wolfgang
Pfister, Stefan M.
von Deimling, Andreas
Jones, David T. W.
Sahm, Felix
Sievers, Philipp
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
title Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
title_full Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
title_fullStr Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
title_full_unstemmed Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
title_short Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
title_sort glioneuronal tumor with atrx alteration, kinase fusion and anaplastic features (gtaka): a molecularly distinct brain tumor type with recurrent ntrk gene fusions
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119244/
https://www.ncbi.nlm.nih.gov/pubmed/36933012
http://dx.doi.org/10.1007/s00401-023-02558-0
work_keys_str_mv AT bogumilhenri glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT sillmartin glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT schrimpfdaniel glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT ismerbritta glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT blumechristina glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT rahmanzaderamin glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT hinzfelix glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT cherkezovasan glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT bananrouzbeh glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT friedeldennis glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT reussdavide glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT seltflorian glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT eckerjonas glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT mildetill glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT pajtlerkristianw glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT schittenhelmjens glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT henchjurgen glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT frankstephan glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT boldthenningb glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT kristensenbjarnewinther glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT scheiedavid glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT melchiorlineac glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT olesenviola glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT sehestedastrid glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT bouedanielr glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT abdullaevzied glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT satgunaseelanlaveniya glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT kurthina glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT seidlitzannekatrin glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT whitechristinel glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT nghokeung glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT shizhifeng glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT haberlerchristine glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT deckertmartina glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT timmermarco glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT goldbrunnerroland glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT tauziedeespariatarnault glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT varletpascale glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT brandnersebastian glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT alexandrescusanda glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT snuderlmatija glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT aldapekenneth glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT korshunovandrey glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT wittolaf glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT heroldmendechristel glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT unterbergandreas glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT wickwolfgang glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT pfisterstefanm glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT vondeimlingandreas glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT jonesdavidtw glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT sahmfelix glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions
AT sieversphilipp glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions